Movement Disorders

Actively Recruiting Studies


fact_group

If you think you may qualify for one of these studies, please contact Neurology Research at (303) 724-4644 or neuroresearch@cuanschutz.edu

 

Parkinson's Disease

COMIRB #Title Principal InvestigatorEligibility & InformationAdvertisement
17-2318A randomized, double blind, placebo-controlled parallel study of tolerability and efficacy of Cannabidiol (CBD) on motor symptoms in Parkinson’s diseaseMaureen Leehey, MDClinical TrialsSee Advertisement
19-2471Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of 36 Weeks of Treatment with NLY01 in Early-stage Parkinson’s DiseaseMaureen Leehey, MDClinical TrialsN/A
16-2308Neurologic Music Therapy for enhancing fine motor control in Parkinson’s DiseaseIsabelle Buard, PhDClinical TrialsSee Advertisement
20-1204The Parkinson’s Progression Markers Initiative (PPMI) Clinical -
Establishing a Deeply Phenotyped PD Cohort
Maureen Leehey, MDClinical TrialsN/A
20-1854Study in Parkinson Disease of Exercise (SPARX3)Cory Christiansen, PhD & Jeanne Feuerstein, MDClinical TrialsN/A
18-1356Peripheral Inflammatory Cytokine and Alpha Synuclein Levels in Parkinson Disease and Essential TremorMaureen Leehey, MDN/AN/A

 

Huntington's Disease

COMIRB #Title Principal InvestigatorEligibility and InformationAdvertisement
16-2308Neurologic Music Therapy for enhancing fine motor control in Parkinson’s Disease and Other Basal Ganglia DisordersIsabelle Buard, PhDN/ASee Advertisement

 

Dystonia

COMIRB #Title Principal InvestigatorEligibility and InformationAdvertisement
20-0290Dystonia Coalition Projects-3Jeanne Feuerstein, MDN/AN/A

 

Ataxia

COMIRB #Title Principal InvestigatorEligibility and InformationAdvertisement
18-1641Clinical Outcome Measures in Friedreich’s AtaxiaTrevor Hawkins, MDClinical TrialsN/A

 

Healthy Volunteer

COMIRB #Title Principal InvestigatorEligibility and InformationAdvertisement
18-1356Peripheral Inflammatory Cytokine and Alpha Synuclein Levels in Parkinson Disease and Essential TremorMaureen Leehey, MDN/AN/A
20-1204The Parkinson’s Progression Markers Initiative (PPMI) Clinical -
Establishing a Deeply Phenotyped PD Cohort
Maureen Leehey, MDClinical TrialsN/A